Caffeine for the Treatment of Apnea in Bronchiolitis: A Randomized Trial

Journal of Pediatrics

Volumn 177, Issue , 2016, Pages 204-211.e3

  Alansari, Khalid ^a,b,c   Toaimah, Fatihi Hassan ^a   Khalafalla, Hany ^a   El Tatawy, Lamiaa Awny ^a   Davidson, Bruce L ^d   Ahmed, Wessam ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

apnea; bronchiolitis; caffeine citrate; respiratory syncytial virus

Indexed keywords

ANTIBIOTIC AGENT; CAFFEINE CITRATE; EPINEPHRINE; SALBUTAMOL; CAFFEINE; CITRIC ACID;

ADENOVIRIDAE; APNEA; ARTICLE; BLOOD GAS ANALYSIS; BOCAPARVOVIRUS; BRADYCARDIA; CONTROLLED STUDY; CORONAVIRIDAE; CRACKLE; CYANOSIS; DISEASE DURATION; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG SAFETY; EMERGENCY CARE; FEMALE; GESTATIONAL AGE; HEART ARRHYTHMIA; HEART RATE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; INFLUENZA VIRUS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONINVASIVE VENTILATION; OXYGEN THERAPY; PARAMYXOVIRINAE; PEDIATRIC INTENSIVE CARE UNIT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY VIRUS; RHABDOMYOLYSIS; RHINOVIRUS; SHOCK; SIDE EFFECT; SINGLE DRUG DOSE; THORAX RADIOGRAPHY; VIRAL BRONCHIOLITIS; WHEEZING; BRONCHIOLITIS; COMPLICATION; DOUBLE BLIND PROCEDURE;

APNEA; BRONCHIOLITIS; CAFFEINE; CITRATES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFANT; MALE;

EID: 84967016189     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.04.060     Document Type: Article

References (32)

1. 1 Koehoorn, M., Karr, C.J., Demers, P.A., Lencar, C., Tamburic, L., Brauer, M., Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics 122 (2008), 1196–1203.
2. 2 Hasegawa, K., Tsugawa, Y., Brown, D.F., Mansbach, J.M., Camargo, C.A. Jr., Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics 132 (2013), 28–36.
3. 3 Jafri, H.S., Wu, X., Makari, D., Henrickson, K.J., Distribution of respiratory syncytial virus subtypes A and B among infants presenting to the emergency department with lower respiratory tract infection or apnea. Pediatr Infect Dis J 32 (2013), 335–340.
4. 4 Staat, M.A., Henrickson, K., Elhefni, H., Groothuis, J., Makari, D., Prevalence of respiratory syncytial virus-associated lower respiratory infection and apnea in infants presenting to the emergency department. Pediatr Infect Dis J 32 (2013), 911–914.
5. 5 Pappano, D.A., Bass, E.S., Respiratory virus-associated apnea. Pediatr Emerg Med Rep 12 (2007), 1–12.
6. 6 Raza, M.W., Blackwell, C.C., Sudden infant death syndrome, virus infections and cytokines. FEMS Immunol Med Microbiol 25 (1999), 85–96.
7. 7 Schiller, O., Levy, I., Pollak, U., Kadmon, G., Nahum, E., Schonfeld, T., Central apnoeas in infants with bronchiolitis admitted to the paediatric intensive care unit. Acta Paediatr 100 (2011), 216–219.
8. 8 Henderson-Smart, D.J., De Paoli, A.G., Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev(12), 2010, CD000140.
9. 9 Schoen, K., Yu, T., Stockmann, C., Spigarelli, M.G., Sherwin, C.M., Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity. Paediatr Drugs 16 (2014), 169–177.
10. 10 Henderson-Smart, D.J., Davis, P.G., Prophylactic methylxanthines for endotracheal extubation in preterm infants. Cochrane Database Syst Rev(12), 2010, CD000139.
11. 11 Sajit, N.T., Steggall, M., Padmakumar, B., Apnoeas in bronchiolitis: is there a role for caffeine?. Arch Dis Child, 90, 2005, 438.
12. 12 Johnston, D.M., Kuzemko, J.A., Virus-induced apnoea and theophylline. Lancet, 340, 1992, 1352.
13. 13 Pappano, D.A., Failure of caffeine to ameliorate respiratory syncytial virus-induced apnea. Open Emerg Med J 3 (2010), 1–2.
14. 14 DeBuse, P., Cartwright, D., Respiratory syncytial virus with apnea treated with theophylline. Med J Aust 2 (1979), 307–308.
15. 15 Tobias, J.D., Caffeine in the treatment of apnea associated with respiratory syncytial virus infection in neonates and infants. South Med J 93 (2000), 294–296.
16. 16 Duffett, M., Liu, D.M., Deshpande, A., Choong, K., Caffeine in bronchiolitis associated apnea: a retrospective cohort study. J Pediatr Intensive Care 2 (2012), 95–98.
17. 17 Cesar, K., Iolster, T., White, D., Latifi, S., Caffeine as treatment for bronchiolitis-related apnoea. J Paediatr Child Health, 48, 2012, 619.
18. 18 Natarajan, G., Lulic-Botica, M.L., Aranda, J.V., Pharmacology review: clinical pharmacology of caffeine in the newborn. Neo Rev 8 (2007), e214–e221.
19. 19 Atkinson, E., Fenton, A.C., Management of apnoea and bradycardia in neonates. Paediatr Child Health 19 (2009), 550–554.
20. 20 Al-balkhi, A., Klonin, H., Marinaki, K., Southall, D.P., Thomas, D.A., Jones, P., et al. Review of treatment of bronchiolitis related apnoea in two centres. Arch Dis Child 90 (2005), 288–291.
21. 21 National Institutes of Health. Consensus development summaries. Infantile apnea and home monitoring. Conn Med 51 (1987), 45–51.
22. 22 Committee on Fetus and Newborn. American Academy of Pediatrics. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 111 (2003), 914–917.
23. 23 Dean AG. Open source statistics for public health. http://www.openepi.com/Random/Random.htm. Accessed October 2011.
24. 24 Alansari, K., Sakran, M., Davidson, B.L., Ibrahim, K., Alrefai, M., Zakaria, I., Oral dexamethasone for bronchiolitis: a randomized trial. Pediatrics 132 (2013), e810–e816.
25. 25 Mansbach, J.M., Piedra, P.A., Stevenson, M.D., Sullivan, A.F., Forgey, T.F., Clark, S., et al. Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics 130 (2012), e492–e500.
26. 26 Schroeder, A.R., Mansbach, J.M., Stevenson, M., Macias, C.G., Fisher, E.S., Barcega, B., et al. Apnea in children hospitalized with bronchiolitis. Pediatrics 132 (2013), e1194–e1201.
27. 27 Kay, R., Kinnersley, N., On the use of the accelerated failure time model as an alternative to the proportional hazards model in the treatment of time to event data: a case study in influenza. Drug Inf J 36 (2002), 571–579.
28. 28 Carol, K.T., Jane, H.H., Donna, M.K., Pediatric dosage handbook. 12th ed., 2006, Lexi-Comp, Hudson (OH), 218–219.
29. 29 Willwerth, B.M., Harper, M.B., Greenes, D.S., Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med 48 (2006), 441–447.
30. 30 Kneyber, M.C., Brandenburg, A.H., de Groot, R., Joosten, K.F., Rothbarth, P.H., Ott, A., et al. Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr 157 (1998), 331–335.
31. 31 Steer, P.A., Flenady, V.J., Shearman, A., Lee, T.C., Tudehope, D.I., Charles, B.G., Periextubation caffeine in preterm neonates: a randomised dose response trial. J Paediatr Child Health 39 (2003), 511–515.
32. 32 Sreenan, C., Lemke, R.P., Hudson-Mason, A., Osiovich, H., High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics 107 (2001), 1081–1083.